SCHEMBL10151647

SCHEMBL10151647

CCN[C@H]1CCCC[C@@H]1C

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FUCA1 P04066 1/20 0.43
EPHX1 P07099 1/20 0.39
TSHR P16473 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 5/20 0.35
TAS1R3 Q7RTX0 4/20 0.35
TAS1R1 Q7RTX1 4/20 0.35
KDM4E B2RXH2 3/20 0.35
GAA P10253 2/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA4 P22748 1/20 0.35
TAS1R2 Q8TE23 1/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10293237 1.00 FUCA1 (0.43) FUCA1EPHX1TSHRNPSR1SMN1; SMN2
SCHEMBL10151965 1.00 FUCA1 (0.43) FUCA1EPHX1TSHRNPSR1SMN1; SMN2
SCHEMBL10069387 1.00 FUCA1 (0.43) FUCA1EPHX1TSHRNPSR1SMN1; SMN2
SCHEMBL19817617 0.98 EPHX1 (0.42) FUCA1EPHX1TSHRNPSR1SMN1; SMN2
SCHEMBL21232876 0.98 EPHX1 (0.42) FUCA1EPHX1TSHRNPSR1SMN1; SMN2
SCHEMBL22170610 0.95
Alcohol SCHEMBL14109089 0.93 FUCA1 (0.44) FUCA1EPHX1TSHRNPSR1SMN1; SMN2
Alcohol SCHEMBL14109615 0.91 EPHX1 (0.43) FUCA1EPHX1TSHRNPSR1SMN1; SMN2
Alcohol SCHEMBL14109452 0.91 EPHX1 (0.43) FUCA1EPHX1TSHRNPSR1SMN1; SMN2
Propanol SCHEMBL14109491 0.89 FUCA1 (0.41) FUCA1EPHX1TSHRNPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1955697-B1 2-AMINOBENZAMIDE DERIVATIVES AS VANILLOID RECEPTOR 1 (VR1) INHIBITORS USEFUL FOR THE TREATMENT OF PAIN OR BLADDER FUNCTION DISORDER ASTELLAS PHARMA INC (JP) 2012-05-02 EP disclosed